期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Design,synthesis and biological activity of cyclohexane-bearing C-glucoside derivatives as SGLT2 inhibitors 被引量:4
1
作者 Shuo Zhang Yu-Li wang +4 位作者 Qun-Chao Wei Wei-Ren Xu Li-Da Tang Gui-Long Zhao jian-wu wang 《Chinese Chemical Letters》 SCIE CAS CSCD 2013年第5期429-432,共4页
Seven cyclohexane-bearing C-glucoside derivatives(7,9,12,13 and 17-19) were designed and synthesized as SGLT2 inhibitors starting from a potent SGLT2 inhibitor we discovered in earlier work, (lS)-1-deoxy-l-[4-meth... Seven cyclohexane-bearing C-glucoside derivatives(7,9,12,13 and 17-19) were designed and synthesized as SGLT2 inhibitors starting from a potent SGLT2 inhibitor we discovered in earlier work, (lS)-1-deoxy-l-[4-methoxy-3-(trans-n-propylcyclohexyl)methylphenyl]-D-glucose(1).The in vitro and in vivo biological activities were evaluated by hSGLT2/hSGLTl inhibition and urinary glucose excretion (UGE),respectively.Among the synthesized compounds 12,the 6-deoxy derivative of 1 was the most active and selective SGLT2 inhibitor(IC_(50)= 1.4nmol/L against hSGLT2;selectivity = 1576).Compound 12 was a potent SGLT2 inhibitor,which could induce more urinary glucose than 1 and dapagliflozin in UGE. 展开更多
关键词 SYNTHESIS C-Glucoside SGLT2 inhibitor Urinary glucose excretion Cyclohexane-bearing
原文传递
The near-infrared dye IR-61 restores erectile function in a streptozotocin-induced diabetes model via mitochondrial protection 被引量:3
2
作者 Xiao-Feng Yue Chong-Xing Shen +10 位作者 jian-wu wang Lin-Yong Dai Qiang Fang Lei Long Yi Zhi Xue-Ru Li Ya-Wei wang Gu-Fang Shen Zu-Juan Liu Chun-Meng Shi Wei-Bing Li 《Asian Journal of Andrology》 SCIE CAS CSCD 2021年第3期249-258,共10页
This study aimed to evaluate the therapeutic effect of IR-61,a novel mitochondrial heptamethine cyanine dye with antioxidant effects,on diabetes mellitus-induced erectile dysfunction(DMED).Eight-week-old male Sprague-... This study aimed to evaluate the therapeutic effect of IR-61,a novel mitochondrial heptamethine cyanine dye with antioxidant effects,on diabetes mellitus-induced erectile dysfunction(DMED).Eight-week-old male Sprague-Dawley rats were intraperitoneally injected with streptozotocin(STZ)to induce type 1 diabetes.Eight weeks after STZ injection,all rats were divided into three groups:the control group,DM group,and DM+IR-61 group.In the DM+IR-61 group,the rats were administered IR-61(1.6 mg kg-1)twice a week by intravenous injection.At week 13,erectile function was evaluated by determining the ratio of the maximal intracavernous pressure to mean arterial pressure,and the penises were then harvested for fluorescent imaging,transmission electron microscopy,histological examinations,and Western blot analysis.Whole-body imaging suggested that IR-61 was highly accumulated in the penis after intravenous injection.IR-61 treatment significantly improved the maximal ICP of diabetic rats.Additionally,IR-61 ameliorated diabetes-induced inflammation,apoptosis,and phenotypic transition of corpus cavernosum smooth muscle cells(CCSMCs)in penile tissue.IR-61 also attenuated mitochondrial damage,reduced reactive oxygen species production in the corpus cavernosum and upregulated sirtuinl(SIRT1),sirtuin3(SIRT3),nuclear factor(erythroid-derived 2)-like 2(Nrf2),and heme oxygenase expression in penile tissue.In conclusion,IR-61 represents a potential therapeutic option for DMED by protecting the mitochondria of CCSMCs,which may be mediated by activation of the SIRT1,SIRT3,and Nrf2 pathways. 展开更多
关键词 corpus cavernosum smooth muscle cells diabetes erectile dysfunction IR-61 MITOCHONDRIA
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部